Veristat

Veristat is a clinical research and consulting organization that helps biotechnology and pharmaceutical companies advance medical products while managing scientific, regulatory, and patient-safety requirements. Its expertise spans the product lifecycle, from development strategy and clinical trials through regulatory submissions and post-market safety monitoring. Veristat supports pharmaceutical drugs, biologics, radiopharmaceuticals, natural health products, and medical devices, including both pre-approval and post-market pharmacovigilance and medical information needs.

Its services include pharmacovigilance system setup and maintenance, audit and inspection support, medical information, individual case safety reports, aggregate safety reports, risk management, and patient-safety support for clinical trials. Across broader development programs, the company also provides strategic and regulatory consulting, clinical operations, medical writing, biostatistics, statistical programming, data management, and submission leadership. Its clinical capabilities include site monitoring, decentralized trials, participant recruitment, trial rescue programs, and rare-disease and natural-history studies.

Veristat serves diverse therapeutic areas, including oncology, neurology, pediatrics, cell and gene therapies, and vaccines, with further expertise across fields such as allergy, dermatology, and respiratory health.